Skip to main content
. 2005 Sep;43(9):4545–4550. doi: 10.1128/JCM.43.9.4545-4550.2005

TABLE 1.

Number of patients with significantly elevated dot immunobinding or Widal agglutination titers

Group No. of sera with positive result when tested with indicated antigen in dot immunobinding (titer ≥ 20,000)
No. of sera with positive result in indicated Widal test
n ST O-HSA
ST LPS
ST O (100 ng) n Widal H
Widal O
100 ng 10 ng 100 ng 10 ng ≥1/80 ≥1/160 ≥1/80 ≥1/160
Typhoid fever 40 28 12 38 34 16 35 27 26 25 22
Nontyphoid fevers 22 2a 1b 1a 1a 0d 22 7f 3a 13 6g
Healthy controls 17 0a 0c 0a 0a 0g NDh ND ND ND ND
a

Significantly different from patients with typhoid fever (P < 0.0001; Fisher's exact test).

b

Significantly different from patients with typhoid fever (P = 0.0226; Fisher's exact test).

c

Significantly different from patients with typhoid fever (P = 0.0114; Fisher's exact test).

d

Significantly different from patients with typhoid fever (P = 0.0005; Fisher's exact test).

e

Significantly different from patients with typhoid fever (P = 0.0012; Fisher's exact test).

f

Significantly different from patients with typhoid fever (P = 0.001; Fisher's exact test).

g

Significantly different from patients with typhoid fever (P = 0.014; Fisher's exact test).

h

ND, not determined.